The cutoff level of free/total prostate specific antigen (f/t PSA) ratios in the diagnosis of prostate cancer: a validation study on a Turkish patient population in different age categories.

作者: Bulent Erol , Murat Tolga Gulpinar , Gurdal Bozdogan , Seyma Ozkanli , Kadir Onem

DOI: 10.1016/J.KJMS.2014.03.008

关键词: Likelihood ratios in diagnostic testingProstate cancerProstatePopulationGynecologyUrologyReceiver operating characteristicProstate-specific antigenProstate biopsyMedicineArea under the curve

摘要: We investigated an optimal cutoff level of free/total PSA ratios (f/t PSA) in predicting prostate cancer different age groups, focusing on the avoidance unnecessary biopsies. A total 4955 men were enrolled into study. Serum tPSA, fPSA, and f/t determined for study population. All males who had suspicious digital rectal examination tPSA > 4 ng/mL underwent transrectal ultrasonography-guided biopsy. Receiver operating characteristic (ROC) curves each group generated by plotting sensitivity versus 1-specificity ratio. The sensitivity, specificity, positive likelihood ratio (PLR), negative (NLR) obtained using various cutoffs groups. There 657 patients with a 4-10 ng/mL. According to specificity f/t% points be 10%, 15%, 10% 50-59 years, 60-69 >70 all ages categories, respectively, initial area under curve (AUC) value 0.81 (95% confidence level: 0.80-0.82) groups detecting cancer. has AUC 0.669 (0.632-0.705) among Ten percent highest PLR 30% lower NLR all-age categories. current shows that use levels should enhance screening decrease number age-related changes warrant further investigation large, multicentric, multinational population improve clinical cutoffs.

参考文章(30)
A. Gorkem Mungan, Bulent Erol, Bulent Akduman, Gurdal Bozdogan, Sibel Kiran, Cetin Yesilli, N. Aydin Mungan, Values for free/total prostate-specific antigen ratio as a function of age : necessity of reference validation in a Turkish population Clinical Chemistry and Laboratory Medicine. ,vol. 45, pp. 912- 916 ,(2007) , 10.1515/CCLM.2007.501
FELIX K.-H. CHUN, PAUL PERROTTE, ALBERTO BRIGANTI, SERGE BENAYOUN, THIERRY LEBEAU, ALVARO RAMIREZ, DANIEL J. LEWINSHTEIN, LUC VALIQUETTE, JEAN-PIERRE GUAY, PIERRE I. KARAKIEWICZ, Prostate specific‐antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer BJUI. ,vol. 98, pp. 50- 53 ,(2006) , 10.1111/J.1464-410X.2006.06193.X
Paul J. Van Cangh, Philippe De Nayer, Luc De Vischer, Philippe Sauvage, Bertrand Tombal, Francis Lorge, François X. Wese, Reinier Opsomer, Free to total Prostate-Specific Antigen (PSA) ratio improves the discrimination between prostate cancer and benign prostatic hyperplasia (BPH) in the diagnostic gray zone of 1.8 to 10 ng/mL total PSA Urology. ,vol. 48, pp. 67- 70 ,(1996) , 10.1016/S0090-4295(96)00613-9
Mark Garzotto, R. Guy Hudson, Laura Peters, Yi-Ching Hsieh, Eduardo Barrera, Motomi Mori, Tomasz M. Beer, Thomas Klein, Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < 10 ng/mL Cancer. ,vol. 98, pp. 1417- 1422 ,(2003) , 10.1002/CNCR.11668
Eiji Kikuchi, Jun Nakashima, Midori Ishibashi, Takashi Ohigashi, Hirotaka Asakura, Masaaki Tachibana, Masaru Murai, Prostate specific antigen adjusted for transition zone volume: the most powerful method for detecting prostate carcinoma. Cancer. ,vol. 89, pp. 842- 849 ,(2000) , 10.1002/1097-0142(20000815)89:4<842::AID-CNCR17>3.0.CO;2-9